Altamira Therapeutics Ltd. CYTOF
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
What this company does
Written from the business description in Altamira Therapeutics Ltd.'s annual report to the U.S. Securities and Exchange Commission, filed 30 April 2025. Every sentence was checked against that document before publication.
Growth
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
Return on equity has no reading this year — return on capital employed, just below, still does: -88%.
The 10-year record
EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue CHF B | ◌ | 0.0 | 0.0 | 0.0 | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ |
| Operating income CHF B | ◌ | ◌ | ◌ | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 |
| EBITDA CHF B | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ |
| Income tax CHF B | ◌ | ◌ | ◌ | −0.0 | −0.0 | −0.0 | 0.0 | −0.0 | −0.0 | 0.0 |
| Net income CHF B | ◌ | ◌ | ◌ | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 |
| Free cash flow CHF B | −0.0 | ◌ | −0.0 | ◌ | ◌ | ◌ | −0.0 | −0.0 | −0.0 | −0.0 |
| EPS, diluted $ | −2.99 | −8.77 | −610.03 | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ |
| Dividend / sh CHF | ◌ | 4.00 | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ |
| Payout % — not applicable: no dividend | — | — | — | — | — | — | — | — | — | — |
| ROE % | ◌ | — | — | −114.5 | −71.9 | −136.9 | — | — | ◌ | ◌ |
| Shares out B | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.04 | 0.05 | 0.03 | 0.00 |
Slide the table for earlier years. "—" not applicable · "◌" not available in our data.
Company facts, as filed
Reconciled in 5 of the 10 fiscal years we could check. 1 of those reconciliations are divergences — the figures exist but don't fit the formula this check expects; that isn't the same as an error. 18 checks were skipped: the balance sheet is not tagged before 2016. 14 checks were skipped: revenue is not tagged before 2021. 13 checks were skipped: EPS is not tagged before 2020.